Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5419]
News [12588]
Articles [170]
Editorials [5]
Conferences [246]
elearning [17]
SIOG COVID-19 working group report and discussion of ethical issues
Dr Nicolò Battisti - The Royal Marsden NHS Foundation Trust, London, UK
SIOG COVID-19 working group report and discussion of ethical issues ( Dr Nicolò Battisti - The Royal Marsden NHS Foundation Trust, London, UK )
12 Nov 2020
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020
Dr Gil Morgan - Skåne University Hospital, Lund, Sweden
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020 ( Dr Gil Morgan - Skåne University Hospital, Lund, Sweden )
9 Nov 2020
Evolving concepts in the diagnosis and staging of multiple myeloma
Dr Jens Hillengass - Roswell Park Comprehensive Cancer Center, Buffalo, USA
Evolving concepts in the diagnosis and staging of multiple myeloma ( Dr Jens Hillengass - Roswell Park Comprehensive Cancer Center, Buffalo, USA )
6 Nov 2020
Recommendations on treating multiple myeloma patients during the pandemic
Dr Jens Hillengass - Roswell Park Comprehensive Cancer Center, Buffalo, USA
Recommendations on treating multiple myeloma patients during the pandemic ( Dr Jens Hillengass - Roswell Park Comprehensive Cancer Center, Buffalo, USA )
6 Nov 2020
SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non...
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
Sotorasib for advanced non-small cell lung cancer
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
Sotorasib for advanced non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of...
Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients ( Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA )
4 Nov 2020
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation
Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation ( Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA )
4 Nov 2020
Development of novel inhibitors of KRASG12C
Dr Kevan Shokat - University of California San Francisco, San Francisco, USA
Development of novel inhibitors of KRASG12C ( Dr Kevan Shokat - University of California San Francisco, San Francisco, USA )
4 Nov 2020
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1...
Dr Julius Strauss - National Institutes of Health, Bethseda, USA
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy ( Dr Julius Strauss - National Institutes of Health, Bethseda, USA )
4 Nov 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation